Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zewei Wang

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
International Journal of Cancer|October 5, 2019
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responsesHan Zeng, Zheng Liu, Zewei Wang, et al.
Journal for Immunotherapy of Cancer|May 7, 2020
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinomaQuan Zhou, Yangyang Qi, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2020
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancerTao Wang, Quan Zhou, Han Zeng, et al.
Oncoimmunology|September 17, 2020
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5<sup>+</sup> CD8<sup>+</sup> T cell abundanceQiuren Huang, Quan Zhou, Hongyu Zhang, et al.
International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Intratumoral TIGIT<sup>+</sup> CD8<sup>+</sup> T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancerZhaopei Liu, Quan Zhou, Zewei Wang, et al.
Urologic Oncology|January 1, 2020
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patientsYang Qu, Zhiyuan Lin, Yu Qi, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
International Journal of Cancer|October 5, 2019
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responsesHan Zeng, Zheng Liu, Zewei Wang, et al.
Journal for Immunotherapy of Cancer|May 7, 2020
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinomaQuan Zhou, Yangyang Qi, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2020
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancerTao Wang, Quan Zhou, Han Zeng, et al.
Oncoimmunology|September 17, 2020
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5<sup>+</sup> CD8<sup>+</sup> T cell abundanceQiuren Huang, Quan Zhou, Hongyu Zhang, et al.
International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Intratumoral TIGIT<sup>+</sup> CD8<sup>+</sup> T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancerZhaopei Liu, Quan Zhou, Zewei Wang, et al.
Urologic Oncology|January 1, 2020
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patientsYang Qu, Zhiyuan Lin, Yu Qi, et al.
Pageof 16